Evotec and Spero Therapeutics Extend Collaboration to Develop Novel Antibacterials

Go back to Evotec and Spero Therapeutics Extend Collaboration to Develop Novel Antibacterials
EATON VANCE TAX-ADVANTAGED DIVIDEND INCOME FUND (NYSE: EVT) Delayed: 28.91 --0 (-0%)
Previous Close $28.91    52 Week High $21.25 
Open $28.91    52 Week Low $16.37 
Day High $28.91    P/E N/A 
Day Low $28.91    EPS $0.00 
Volume 16       

EATON VANCE TAX-ADVANTAGED DIVIDEND INCOME FUND (NYSE: EVT) Delayed: 28.91 --0 (-0%)
Previous Close $28.91    52 Week High $21.25 
Open $28.91    52 Week Low $16.37 
Day High $28.91    P/E N/A 
Day Low $28.91    EPS $0.00 
Volume 16       

Evotec Aktiengesellschaft American Depositary Share (AMEX: EVTCY) Delayed: 22.96 --0 (-0%)
Previous Close $22.96    52 Week High $11.93 
Open $22.96    52 Week Low $6.56 
Day High $22.96    P/E N/A 
Day Low $22.96    EPS $0.00 
Volume 1,020,350       

Muenchener Re Group AG Unsponsored ADR (AMEX: MURGY) Delayed: 11.95 --0 (-0%)
Previous Close $11.95    52 Week High $20.93 
Open $11.95    52 Week Low $15.56 
Day High $11.95    P/E N/A 
Day Low $11.95    EPS $0.00 
Volume 785